[Commentary on] Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer Journal Article
| Author: | Dickler, M. N. |
| Article Title: | [Commentary on] Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer |
| Keywords: | gene amplification; disease progression; breast neoplasms -- drug therapy; antibodies, monoclonal -- adverse effects; antibodies, monoclonal -- therapeutic use; neoplasm metastasis -- drug therapy; breast neoplasms -- prognosis; breast neoplasms -- mortality; female |
| Journal Title: | Women's Oncology Review |
| Volume: | 2 |
| Issue: | 2 |
| ISSN: | 1473-3404 |
| Publisher: | Taylor & Francis Group |
| Date Published: | 2002-06-01 |
| Start Page: | 179 |
| End Page: | 180 |
| Language: | English |
| ACCESSION: | 2004152174 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| DOI/URL: | |
| Notes: | Accession Number: 2004152174 -- Entry Date: 20040903 -- Revision Date: 20090313 -- Publication Type: journal article; abstract; commentary -- Original Study: Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L et al -- Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer -- J CLIN ONCOL 2002; 20: 719-26 -- Journal Subset: Biomedical; Editorial Board Reviewed; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 101128014. -- Source: cin20 |
MSK Authors
-
262Dickler